Ephedra Athletic Performance Claims Targeted In FDA Warning Letters

Athletic performance claims for ephedrine alkaloid-containing dietary supplements should be discontinued unless they can be scientifically supported, FDA states in Feb. 28 warning letters to 26 marketers